Outpatient transplantation during the COVID19 pandemic: stretching the limits for continuing care

Colunga Pedraza, Perla Rocío y Colunga Pedraza, Julia Esther y Gómez de León, Andrés y Bustillos Muñoz, Mónica y Osorno Rodríguez, Karen Lorena y Hawing Zárate, José Ángel y González Llano, Óscar y Jiménez Antolínez, Yajaira Valentine y Cantú Rodríguez, Olga Graciela y Gutiérrez Aguirre, César Homero y Gómez Almaguer, David (2020) Outpatient transplantation during the COVID19 pandemic: stretching the limits for continuing care. Blood, 136 (Supple). p. 31. ISSN 0006-4971

Vista previa

Texto 23255.pdf - Versión Aceptada Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (652kB) | Vista previa

Resumen

COVID-19 has transformed stem cell transplantation (HSCT) dynamics throughout the world. Bone Marrow Transplantation units are facing many challenges complicating admission; deferrals in transplant schedules and even temporary closure. Delay in treatment may have a negative impact in outcomes. Outpatient care has been an alternative to hospital care in patients undergoing HSCT since the 1990s. Potential advantages include improved patient independence and satisfaction, improved quality of life, and less hospital resource utilization, which is of particular importance during this epidemic. In this prospective cohort study, we investigated the impact of the pandemic in our outpatient HSCT program.

Actions (login required)

Ver elemento